Evaluation of pH- responsive poly(styrene-co-maleic acid) copolymer nanoparticles for the encapsulation and pH- dependent release of ketoprofen and tocopherol model drugs

Ágota Deák, Dániel Sebők, Edit Csapó, A. Bérczi, I. Dékány, L. Zimányi, László Janovák

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pH- induced intelligent drug release ability of poly(styrene-co-maleic acid) copolymer nanoparticles (SMA NPs; d = 22.4 ± 3.1 nm) is presented using poorly water soluble ketoprofen (KETO) and α-Tocopherol (TP) model drugs. Increasing styrene content of the copolymer led to lower surface charge (from −28.4 to −15.0 meq/100 g) and the different styrene/maleic acid ratio (SMA#1: 1:2; SMA#2: 2:1 and SMA#3: 3:1) influences the pH- dependent solubility properties. Because of the polyanionic nature, homogeneous polymer solution was obtained at higher pH, while at lower pH nanoparticles were formed. The corresponding cut- off pH values showed increasing tendency with increasing hydrophobicity (pH = 3.12, 4.22 and 5.44 for SMA#1, 2 and 3, respectively). Next the hydrophobic, non- water soluble KETO and TP drug cores were coated with SMA#2 shell. The polymer-stabilized drug particles provided stable dispersion in aqueous environment, i.e. the prepared polymer shell increased the water dispersibility of the initial hydrophobic drugs. According to the experiments the release of low crystallinity KETO drug was almost complete at physiological pH (=7.40), while at acidic pH the released amount of model drug was only about 30%. Similar kinetic release profile was obtained in the case of more hydrophobic TP drug without charged groups and it indicates that the drug release was primarily controlled by the pH- responsive polymer particles instead of the pH- dependent solubility of the model drug. The prepared NPs could be useful in all areas where the alkaline pH value causes problems, for example in the case of female genital diseases of fungal origin.

Original languageEnglish
Pages (from-to)361-368
Number of pages8
JournalEuropean Polymer Journal
Volume114
DOIs
Publication statusPublished - May 1 2019

Fingerprint

tocopherol
Ketoprofen
Tocopherols
Encapsulation
Styrene
polystyrene
copolymers
drugs
Copolymers
spectral mixture analysis
Nanoparticles
nanoparticles
acids
Acids
evaluation
Polymers
Solubility
Pharmaceutical Preparations
Water
Polymer solutions

Keywords

  • Copolymer nanoparticles
  • Hydrophobic drugs
  • Improved solubility
  • pH- sensitive drug release

ASJC Scopus subject areas

  • Physics and Astronomy(all)
  • Organic Chemistry
  • Polymers and Plastics
  • Materials Chemistry

Cite this

Evaluation of pH- responsive poly(styrene-co-maleic acid) copolymer nanoparticles for the encapsulation and pH- dependent release of ketoprofen and tocopherol model drugs. / Deák, Ágota; Sebők, Dániel; Csapó, Edit; Bérczi, A.; Dékány, I.; Zimányi, L.; Janovák, László.

In: European Polymer Journal, Vol. 114, 01.05.2019, p. 361-368.

Research output: Contribution to journalArticle

@article{70202347019f44ec9d5cf5e27953f86a,
title = "Evaluation of pH- responsive poly(styrene-co-maleic acid) copolymer nanoparticles for the encapsulation and pH- dependent release of ketoprofen and tocopherol model drugs",
abstract = "The pH- induced intelligent drug release ability of poly(styrene-co-maleic acid) copolymer nanoparticles (SMA NPs; d = 22.4 ± 3.1 nm) is presented using poorly water soluble ketoprofen (KETO) and α-Tocopherol (TP) model drugs. Increasing styrene content of the copolymer led to lower surface charge (from −28.4 to −15.0 meq/100 g) and the different styrene/maleic acid ratio (SMA#1: 1:2; SMA#2: 2:1 and SMA#3: 3:1) influences the pH- dependent solubility properties. Because of the polyanionic nature, homogeneous polymer solution was obtained at higher pH, while at lower pH nanoparticles were formed. The corresponding cut- off pH values showed increasing tendency with increasing hydrophobicity (pH = 3.12, 4.22 and 5.44 for SMA#1, 2 and 3, respectively). Next the hydrophobic, non- water soluble KETO and TP drug cores were coated with SMA#2 shell. The polymer-stabilized drug particles provided stable dispersion in aqueous environment, i.e. the prepared polymer shell increased the water dispersibility of the initial hydrophobic drugs. According to the experiments the release of low crystallinity KETO drug was almost complete at physiological pH (=7.40), while at acidic pH the released amount of model drug was only about 30{\%}. Similar kinetic release profile was obtained in the case of more hydrophobic TP drug without charged groups and it indicates that the drug release was primarily controlled by the pH- responsive polymer particles instead of the pH- dependent solubility of the model drug. The prepared NPs could be useful in all areas where the alkaline pH value causes problems, for example in the case of female genital diseases of fungal origin.",
keywords = "Copolymer nanoparticles, Hydrophobic drugs, Improved solubility, pH- sensitive drug release",
author = "{\'A}gota De{\'a}k and D{\'a}niel Sebők and Edit Csap{\'o} and A. B{\'e}rczi and I. D{\'e}k{\'a}ny and L. Zim{\'a}nyi and L{\'a}szl{\'o} Janov{\'a}k",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.eurpolymj.2019.03.003",
language = "English",
volume = "114",
pages = "361--368",
journal = "European Polymer Journal",
issn = "0014-3057",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Evaluation of pH- responsive poly(styrene-co-maleic acid) copolymer nanoparticles for the encapsulation and pH- dependent release of ketoprofen and tocopherol model drugs

AU - Deák, Ágota

AU - Sebők, Dániel

AU - Csapó, Edit

AU - Bérczi, A.

AU - Dékány, I.

AU - Zimányi, L.

AU - Janovák, László

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The pH- induced intelligent drug release ability of poly(styrene-co-maleic acid) copolymer nanoparticles (SMA NPs; d = 22.4 ± 3.1 nm) is presented using poorly water soluble ketoprofen (KETO) and α-Tocopherol (TP) model drugs. Increasing styrene content of the copolymer led to lower surface charge (from −28.4 to −15.0 meq/100 g) and the different styrene/maleic acid ratio (SMA#1: 1:2; SMA#2: 2:1 and SMA#3: 3:1) influences the pH- dependent solubility properties. Because of the polyanionic nature, homogeneous polymer solution was obtained at higher pH, while at lower pH nanoparticles were formed. The corresponding cut- off pH values showed increasing tendency with increasing hydrophobicity (pH = 3.12, 4.22 and 5.44 for SMA#1, 2 and 3, respectively). Next the hydrophobic, non- water soluble KETO and TP drug cores were coated with SMA#2 shell. The polymer-stabilized drug particles provided stable dispersion in aqueous environment, i.e. the prepared polymer shell increased the water dispersibility of the initial hydrophobic drugs. According to the experiments the release of low crystallinity KETO drug was almost complete at physiological pH (=7.40), while at acidic pH the released amount of model drug was only about 30%. Similar kinetic release profile was obtained in the case of more hydrophobic TP drug without charged groups and it indicates that the drug release was primarily controlled by the pH- responsive polymer particles instead of the pH- dependent solubility of the model drug. The prepared NPs could be useful in all areas where the alkaline pH value causes problems, for example in the case of female genital diseases of fungal origin.

AB - The pH- induced intelligent drug release ability of poly(styrene-co-maleic acid) copolymer nanoparticles (SMA NPs; d = 22.4 ± 3.1 nm) is presented using poorly water soluble ketoprofen (KETO) and α-Tocopherol (TP) model drugs. Increasing styrene content of the copolymer led to lower surface charge (from −28.4 to −15.0 meq/100 g) and the different styrene/maleic acid ratio (SMA#1: 1:2; SMA#2: 2:1 and SMA#3: 3:1) influences the pH- dependent solubility properties. Because of the polyanionic nature, homogeneous polymer solution was obtained at higher pH, while at lower pH nanoparticles were formed. The corresponding cut- off pH values showed increasing tendency with increasing hydrophobicity (pH = 3.12, 4.22 and 5.44 for SMA#1, 2 and 3, respectively). Next the hydrophobic, non- water soluble KETO and TP drug cores were coated with SMA#2 shell. The polymer-stabilized drug particles provided stable dispersion in aqueous environment, i.e. the prepared polymer shell increased the water dispersibility of the initial hydrophobic drugs. According to the experiments the release of low crystallinity KETO drug was almost complete at physiological pH (=7.40), while at acidic pH the released amount of model drug was only about 30%. Similar kinetic release profile was obtained in the case of more hydrophobic TP drug without charged groups and it indicates that the drug release was primarily controlled by the pH- responsive polymer particles instead of the pH- dependent solubility of the model drug. The prepared NPs could be useful in all areas where the alkaline pH value causes problems, for example in the case of female genital diseases of fungal origin.

KW - Copolymer nanoparticles

KW - Hydrophobic drugs

KW - Improved solubility

KW - pH- sensitive drug release

UR - http://www.scopus.com/inward/record.url?scp=85062440685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062440685&partnerID=8YFLogxK

U2 - 10.1016/j.eurpolymj.2019.03.003

DO - 10.1016/j.eurpolymj.2019.03.003

M3 - Article

AN - SCOPUS:85062440685

VL - 114

SP - 361

EP - 368

JO - European Polymer Journal

JF - European Polymer Journal

SN - 0014-3057

ER -